Orforglipron Cuts Systolic BP 6.1 mm Hg in ATTAIN Analyses, GLP-1 Peptide Data Show
Post hoc ATTAIN-1 and ATTAIN-2 analyses presented at AHA 2026 show oral orforglipron lowered office systolic BP versus placebo over 72 weeks, partly beyond weight loss.
Read article →